EVEON carried out many innovative projects in 2020. This new year is also promising for the company driven forward by this positive dynamics.

EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.

The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.

Article OnDrugDelivery about the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.

New digital event, Les Rencontres - Medical Device Development, on October 22.
EVEON as a JBT HubUp allliance member will be part of this event.

EVEON is proud to be part, again in 2020, of Team Excellence - bpifrance.

Since March the 16th, we decided to maintain our operations to meet your needs.

EVEON has exhibited at Pharmapack, on February 5-6, 2020, in Paris (France). 

EVEON will be at the 12^th annual conference SMI Pre-filled syringes and inejctable drug devices, on January 15-16, in London (UK). 

EVEON was at the 8^th edition of BioFIT, on December 10-11, in Marseille (France).